Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...
In October 2025, Sharp announced plans to invest $100 million across its United States and European facilities to expand ...
The expanded collaboration looked to advance innovative science through integration of research. development and ...
On the first day of the JPM Healthcase Conference, AbbVie announced that it would acquire the global rights outside China to ...
TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, ...
NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
Dealbreaker on MSN
Takeda R&D exec explains how $1.2B deal could become one of the biggest bargains in drug history
Bispecific antibodies are one of the hottest areas for drug research and dealmaking, and several of them were discussed this ...
International Healthcare Week is set to return to Thailand (8-10 July 2026, Queen Sirikit National Convention Center, Bangkok ...
Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyond Single-Asset Focus ...
The ‘KojoX’ method of cloning facilities around the globe keeps the CDMO agile in an industry fractured by geopolitical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results